CGTX vs. RXRX
CGTX (Cognition Therapeutics, Inc.) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CGTX returned -13.94%/yr vs -19.32%/yr for RXRX. At a 0.23 correlation, their price movements are largely independent.
Performance
CGTX vs. RXRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CGTX achieves a -19.26% return, which is significantly lower than RXRX's -12.96% return.
CGTX
- 1D
- 0.00%
- 1M
- -9.92%
- 6M
- -22.70%
- YTD
- -19.26%
- 1Y
- 92.10%
- 3Y*
- -13.94%
- 5Y*
- —
- 10Y*
- —
RXRX
- 1D
- -5.32%
- 1M
- 13.02%
- 6M
- -23.61%
- YTD
- -12.96%
- 1Y
- -32.58%
- 3Y*
- -19.32%
- 5Y*
- -38.40%
- 10Y*
- —
CGTX vs. RXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CGTX Cognition Therapeutics, Inc. | -19.26% | 92.50% | -62.09% | -11.90% | -66.77% | -47.98% |
RXRX Recursion Pharmaceuticals, Inc. | -12.96% | -39.50% | -31.44% | 27.89% | -54.99% | -14.35% |
Correlation
The correlation between CGTX and RXRX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Oct 8, 2021 | 0.23 |
Fundamentals
CGTX:
$80.20M
RXRX:
$1.59B
CGTX:
-$0.23
RXRX:
-$1.12
CGTX:
3.25
RXRX:
1.84
CGTX:
$0.00
RXRX:
$66.29M
CGTX:
-$129.00K
RXRX:
-$22.83M
CGTX:
-$23.57M
RXRX:
-$505.90M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CGTX vs. RXRX — Risk / Return Rank
CGTX
RXRX
CGTX vs. RXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cognition Therapeutics, Inc. (CGTX) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CGTX | RXRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.96 | ||
| Sortino ratioReturn per unit of downside risk | +2.07 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 0.95 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.69 | -0.65 | +1.34 |
| Martin ratioReturn relative to average drawdown | 1.04 | -0.98 | +2.03 |
Loading charts...
Drawdowns
CGTX vs. RXRX - Drawdown Comparison
The maximum CGTX drawdown since its inception was -98.16%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for CGTX and RXRX.
Loading charts...
Drawdown Indicators
| CGTX | RXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.16% | -93.13% | -5.03% |
Max Drawdown (1Y)Largest decline over 1 year | -81.30% | -58.17% | -23.13% |
Max Drawdown (3Y)Largest decline over 3 years | -90.88% | -82.09% | -8.79% |
Max Drawdown (5Y)Largest decline over 5 years | — | -92.11% | — |
Current DrawdownCurrent decline from peak | -91.60% | -91.39% | -0.21% |
Average DrawdownAverage peak-to-trough decline | -84.36% | -75.60% | -8.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.71% | 38.43% | +15.28% |
Volatility
CGTX vs. RXRX - Volatility Comparison
Cognition Therapeutics, Inc. (CGTX) has a higher volatility of 55.80% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 15.85%. This indicates that CGTX's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CGTX | RXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 55.80% | 15.85% | +39.95% |
Volatility (6M)Calculated over the trailing 6-month period | 89.67% | 45.37% | +44.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 136.30% | 70.10% | +66.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 119.82% | 93.58% | +26.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 119.82% | 93.21% | +26.61% |
Dividends
CGTX vs. RXRX - Dividend Comparison
Neither CGTX nor RXRX has paid dividends to shareholders.
Financials
CGTX vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Cognition Therapeutics, Inc. and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CGTX and RXRX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CGTX has higher volatility (55.80%) compared to RXRX (15.85%). In terms of maximum drawdown, CGTX dropped -98.16% vs RXRX's -93.13%.
CGTX currently has the higher Sharpe Ratio (0.42 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CGTX and RXRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer